| Home | Bolesti | Dijagnostika | Lijekovi | Radovi | Novosti | Forum | Linkovi |
luk
Second Congress of Cardiology and Angiology of Bosnia & Herzegovina

 

PTCA - STENT ANGIOPLASTY IN TREATMENT OF CORONARY HEART DISEASE
M. Merić, I. Terzić, Z. Kušljugić and E. Halilović.
Cardiovascular Clinic, University Clinical Center Tuzla, Bosnia and Herzegovina

Coronary stenting has become the primary therapeutic option for percutaneous treatment of many coronary lesions, since the risk of subacute stent thrombosis and bleeding complications has been reduced due to the new antithrombotic regimens, new stent construction, coated stents and high pressure stent expansion. Since September 1998, 243 patients i.e. 274 coronary lesions were subject of stent implantation in our institution. 215 patients had single vessel disease, 25 patients had stents on two vessels and 3 patients had three vessel diseases. Primary stenting was performed in 92 patients. Out of total number of patients, there were 194 males and 49 females. Most of the lesions were on LAD (198 patients), in 36 patients lesions were on CX and in 40 patients on RCA. Stenosis diameter before the procedure was 82% and after the procedure average diameter was 5%. There were no peri-procedural deaths, non-fatal Q or non Q wave infarctions or stroke. 5 patients had abrupt closure out of which one was treated surgically, 4 were solved with PTCA or stent. Subacute occlusion was observed in 3 patients (mean time 7 days), while two patients died. Repeated revascularisation was performed with PTCA in 3 patients and 1 patient was referred to surgery after 3 to 7 months. None of patients had bleeding complications associated with transfusion or vascular surgery.

Drugi kongres kardiologa i angiologa Bosne i Hercegovine
HealthBosnia.com - ima autorska prava na ovu stranu. Svako objavljivanje
teksta ili dijelova ovog teksta je moguće samo uz saglasnost HealthBosnia.com
© 1999-2001, by HealthBosnia.com, e-mail medmaster@koming.com. ALL RIGHTS RESERVED.